You are here » Home » Companies » Company Overview » Rekvina Labs Ltd

Rekvina Labs Ltd.

BSE: 526075 Sector: Health care
NSE: N.A. ISIN Code: INE092O01028
BSE 00:00 | 11 Mar Rekvina Labs Ltd
NSE 05:30 | 01 Jan Rekvina Labs Ltd
OPEN 4.17
PREVIOUS CLOSE 4.17
VOLUME 1
52-Week high 5.05
52-Week low 3.95
P/E
Mkt Cap.(Rs cr) 3
Buy Price 4.15
Buy Qty 1000.00
Sell Price 4.20
Sell Qty 8.00
OPEN 4.17
CLOSE 4.17
VOLUME 1
52-Week high 5.05
52-Week low 3.95
P/E
Mkt Cap.(Rs cr) 3
Buy Price 4.15
Buy Qty 1000.00
Sell Price 4.20
Sell Qty 8.00

Rekvina Labs Ltd. (REKVINALABS) - Company History

Rekvina Labs Ltd was incorporated on 1st November 1988. The Company is registered in England and Wales as a Public Limited Company. The company is mainly engaged in manufacturing and marketing of pharmaceutical products. It presently operates into one business segment i.e. copper extrusion.During FY2015 the company sub divided its existing equity shares in such a manner that every shareholder holding 1 equity share of Rs. 10/- each is issued 2 equity shares of Rs. 5/- each. During the year 2017 the Company issued a total of 10769867 shares. Of this total 9043518 shares were issued under the Mobeus VCTs' Linked Offer for Subscription launched on 10 December 2014; and 1726349 shares were issued under Company's Dividend Investment Scheme.During the year 2017 the Company bought back 553800 of its own shares at an average price of 95.28 pence per share and a total cost of 527637 including expenses. These shares represented 0.9% of the issued share capital of Company at 1 October 2014. All shares bought back by Company during the year 2017 were subsequently cancelled.